The SPECTRUM of findings in treatment options for recurrent/metastatic head and neck cancer.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Comparative Effectiveness Research

• Publication date

  2013-11-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.2217/cer.13.72PMID 24236791
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.

  2013cited by this paper
• Human papillomavirus (HPV) in young patients with head and neck squamous cell carcinoma.

  2013cited by this paper
• Progression-free survival (PFS) as a measure of efficacy for anti-EGFR antibodies in recurrent/metastatic (R/M) squamous cell carcinoma of head and neck (SCCHN).

  2013cited by this paper
• p16 expression as a human papillomavirus (HPV)-independent prognostic biomarker in non-oropharyngeal squamous cell carcinoma (non-OPSCC).

  2013cited by this paper
• Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial.

  2011cited by this paper
• Platinum-based chemotherapy plus cetuximab in head and neck cancer.

  2008cited by this paper
• Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy.

  2007cited by this paper
• Epidermal growth factor receptor blockade potentiates apoptosis mediated by Paclitaxel and leads to prolonged survival in a murine model of oral cancer.

  2003cited by this paper
• Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis.

  1994cited by this paper

• Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy

  2021cites this paper
• Endothelial growth factor receptor inhibitors in recurrent metastatic cancer of the head and neck

  2016cites this paper
• Targeted Therapies in HPV-positive and -negative HNSCC - Alteration of EGFR and VEGFR-2 Expression In Vitro.

  2016cites this paper
• Controversies and role of HPV16 in recurrent/metastatic squamous cell cancers of the head and neck.

  2014cites this paper
• The role of HPV status in recurrent/metastatic squamous cell carcinoma of the head and neck.

  2014cites this paper